Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T Ho

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Pathology|March 1, 1997
The utility of patient age in evaluating prostate cancerH T Poteat, G T Ho, M L Lee, et al.
Alimentary Pharmacology & Therapeutics|May 15, 2004
Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgeryG T Ho, C Mowat, C J R Goddard, et al.
Gut|October 19, 2006
Lack of association of the pregnane X receptor (PXR/NR1I2) gene with inflammatory bowel disease: parallel allelic association study and gene wide haplotype analysisG-T Ho, N Soranzo, S K Tate, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 17, 2007
Outcomes of the rectal remnant following colectomy for ulcerative colitisR R W Brady, M H S Collie, G T Ho, et al.
QJM : Monthly Journal of the Association of Physicians|January 14, 2012
Multiple sclerosis in the context of TNF blockade and inflammatory bowel diseaseN C Hare, D P J Hunt, K Venugopal, et al.
Annals of Surgical Oncology|March 1, 1994
Prostate cancer screening: role of the digital rectal examination and prostate-specific antigenJ P Richie, L R Kavoussi, G T Ho, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitisC W Lees, D Heys, G T Ho, et al.
The American Journal of Gastroenterology|March 6, 2009
Fecal calprotectin predicts the clinical course of acute severe ulcerative colitisG T Ho, H M Lee, G Brydon, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2007
The use of adalimumab in the management of refractory Crohn's diseaseG-T Ho, L Smith, S Aitken, et al.
Gut|June 5, 2008
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitisC L Noble, A R Abbas, J Cornelius, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Pathology|March 1, 1997
The utility of patient age in evaluating prostate cancerH T Poteat, G T Ho, M L Lee, et al.
Alimentary Pharmacology & Therapeutics|May 15, 2004
Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgeryG T Ho, C Mowat, C J R Goddard, et al.
Gut|October 19, 2006
Lack of association of the pregnane X receptor (PXR/NR1I2) gene with inflammatory bowel disease: parallel allelic association study and gene wide haplotype analysisG-T Ho, N Soranzo, S K Tate, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 17, 2007
Outcomes of the rectal remnant following colectomy for ulcerative colitisR R W Brady, M H S Collie, G T Ho, et al.
QJM : Monthly Journal of the Association of Physicians|January 14, 2012
Multiple sclerosis in the context of TNF blockade and inflammatory bowel diseaseN C Hare, D P J Hunt, K Venugopal, et al.
Annals of Surgical Oncology|March 1, 1994
Prostate cancer screening: role of the digital rectal examination and prostate-specific antigenJ P Richie, L R Kavoussi, G T Ho, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitisC W Lees, D Heys, G T Ho, et al.
The American Journal of Gastroenterology|March 6, 2009
Fecal calprotectin predicts the clinical course of acute severe ulcerative colitisG T Ho, H M Lee, G Brydon, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2007
The use of adalimumab in the management of refractory Crohn's diseaseG-T Ho, L Smith, S Aitken, et al.
Gut|June 5, 2008
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitisC L Noble, A R Abbas, J Cornelius, et al.
Pageof 4